We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$181M
AUM Growth
+$14.5M
Cap. Flow
+$14.5M
Cap. Flow %
8%
Top 10 Hldgs %
46.73%
Holding
61
New
30
Increased
7
Reduced
10
Closed
12

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.19M
2
CI icon
Cigna
CI
+$6.79M
3
HUM icon
Humana
HUM
+$5.21M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$4.98M
5
HCA icon
HCA Healthcare
HCA
+$4.54M

Top Sells

Rank Stock Value
1
GYRE icon
Gyre Therapeutics
GYRE
+$15.9M
2
SNY icon
Sanofi
SNY
+$10.2M
3
BIIB icon
Biogen
BIIB
+$8.73M
4
VKTX icon
Viking Therapeutics
VKTX
+$6.62M
5
LLY icon
Eli Lilly
LLY
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 80.02%
2 Financials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
26
Alnylam Pharmaceuticals
ALNY
$38.5B
$2.94M 1.62%
+29,835
New +$2.96M
INCY icon
27
Incyte
INCY
$26B
$2.81M 1.56%
+42,000
New +$2.87M
RVNC
28
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.78M 1.54%
+101,292
New +$3.04M
UNH icon
29
UnitedHealth
UNH
$389B
$2.74M 1.51%
11,165
-19,235
-63% -$4.62M
VKTX icon
30
Viking Therapeutics
VKTX
$3.93B
$2.67M 1.48%
281,304
-995,541
-78% -$6.62M
MCK icon
31
McKesson
MCK
$104B
$2.33M 1.29%
+17,500
New +$2.56M
CFMS
32
DELISTED
Conformis, Inc. Common Stock
CFMS
$2.06M 1.14%
65,781
-22,246
-25% -$769K
HRC
33
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.87M 1.04%
21,449
– –
WCG
34
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.61M 0.89%
6,557
-22,096
-77% -$4.81M
RETA
35
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.53M 0.85%
+43,842
New +$1.34M
GWPH
36
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.5M 0.83%
+10,740
New +$1.53M
PINC
37
PUT
DELISTED
Premier
PINC
$1.46M 0.8%
+40,000
New +$1.33M
WST icon
38
PUT
West Pharmaceutical
WST
$23.7B
$1.4M 0.77%
+14,100
New +$1.3M
ZTS icon
39
PUT
Zoetis
ZTS
$32.5B
$1.36M 0.75%
+16,000
New +$1.35M
ACH
40
Accendra Health
ACH
$249M
$1.25M 0.69%
75,000
-198,640
-73% -$3.22M
COR icon
41
Cencora
COR
$62.2B
$1.18M 0.65%
+13,840
New +$1.22M
PFNX
42
DELISTED
Pfenex Inc.
PFNX
$1.02M 0.57%
+189,519
New +$1.1M
XLRN
43
PUT
DELISTED
Acceleron Pharma
XLRN
$810K 0.45%
+16,700
New +$608K
AXSM icon
44
Axsome Therapeutics
AXSM
$12.1B
$619K 0.34%
193,290
– –
ATNM icon
45
Actinium Pharmaceuticals
ATNM
$27.2M
$558K 0.31%
29,080
-6,793
-19% -$86.1K
ARAV
46
DELISTED
Aravive, Inc. Common Stock
ARAV
$504K 0.28%
+41,442
New +$427K
CTIC
47
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$157K 0.09%
+31,600
New +$138K
OCGN icon
48
Ocugen
OCGN
$420M
$98K 0.05%
+653
New +$102K
IMUX icon
49
PUT
Immunic
IMUX
$182M
$95K 0.05%
+35
New +$80.9K
BIIB icon
50
Biogen
BIIB
$30.4B
– –
-31,900
Closed -$8.73M
1
2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Sio Capital Management held 61 positions worth $181M, up 8.7% from $166M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sio Capital Management deployed $14.5M of net new capital in Q2 2018, opening 30 new positions and adding to 7 existing holdings. Its largest new stake was Cardinal Health: 126,770 shares worth $6.19M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 86% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Gyre Therapeutics, an estimated $15.9M trimmed.

  • Sio Capital Management's largest Q2 2018 buy was Cardinal Health: 126,770 shares worth $6.19M.
  • Sio Capital Management added most to HCA Healthcare in Q2 2018, an estimated $4.54M increase.
  • Sio Capital Management's biggest Q2 2018 reduction was Gyre Therapeutics, cutting an estimated $15.9M.
  • Sio Capital Management fully exited Biogen in Q2 2018, selling an estimated $8.73M.
  • Sio Capital Management's ten largest holdings make up 47% of its $181M portfolio in Q2 2018.
  • Sio Capital Management opened 30 new positions and closed 12 in Q2 2018.
  • Sio Capital Management's portfolio value rose 8.7% quarter-over-quarter to $181M.

Based on Sio Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.